Press "Enter" to skip to content

Catalyst Pharma files lawsuit against U.S. FDA on Jacobus Pharma drug approval

Ruzurgi was approved last month for treating Lambert-Eaton myasthenic syndrome.

Original source: https://health.economictimes.indiatimes.com/news/pharma/catalyst-pharma-files-lawsuit-against-u-s-fda-on-jacobus-pharma-drug-approval/69764804?utm_source=RSS&utm_medium=ETRSS

Also Read:   Hyderabad Pharma City to attract Rs 64k investments: T'gana Min